Elevance Health, Inc. (NYSE:ELV – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports.

Asian shares mostly rose Thursday after U.S. President Donald Trump agreed with Russian leader Vladimir Putin to start talks ...

Deschutes County drug agents recently conducted two simultaneous raids in southeast and northwest Bend, charging two people ...

The 120-acre mixed-use NorthPointe development was announced years ago but still hasn't made much observable progress.

The Raleigh, North Carolina-based company said it had profit of $4.79 per share. The results exceeded Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment ...

When multiple Oscar nominee Chris Sanders took on adapting Peter Brown’s beloved children’s book, “The Wild Robot,” he wanted ...